MINT-RISPERIDON
MINT PHARMACEUTICALS INC
Quick answers
Is there a shortage of MINT-RISPERIDON in Canada?
No. There is no current shortage of MINT-RISPERIDON 0.25MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
PMS-RISPERIDONE
PHARMASCIENCE INC
ACT RISPERIDONE
ACTAVIS PHARMA COMPANY
RATIO-RISPERIDONE
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
Other Products
RISPERDAL ORAL SOLUTION
JANSSEN INC
APO-RISPERIDONE
APOTEX INC
RISPERDAL M-TAB
JANSSEN INC
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DIN
02359790
Strength
0.25MG
Dosage Form
Tablet
Route
Oral
Compare with another product →
Product Monograph
Product monograph is not available from Health Canada
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from MINT PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
300MG · DIN 02480956
25MG · DIN 02468859
10MG · DIN 02468840
200MG · DIN 02524708
800MG · DIN 02524724
400MG · DIN 02524716
70.0MG · DIN 02394871
10MG · DIN 02362678
5MG · DIN 02362651
1MG · DIN 02393573
5MG · DIN 02495449
2.5MG · DIN 02495430